Search Results
Dr. David Steensma on Myelodysplastic Syndrome
David Steensma, MD, on Treatment Options for Myelodysplastic Syndromes
ASH Impact Series: David Steensma, MD - Examining Current Research Initiatives in MDS
Dr. David Steensma shares findings from the H3B-8800 clinical trial for myeloid malignancies
MDS: what's the impact of early diagnosis?
Dr. David Steensma on Midostaurin and its Future Uses in Acute Leukemia
ASH Meeting on Hematologic Malignancies: David Steensma, MD
State of the art: MDS
How to treat difficult forms of MDS
Treating adult leukemia: Dr. David Steensma| Dana-Farber Cancer Institute
Conversations with Innovators: David Steensma, MD
Expert Perspectives: Myeloid Disorders